Ocular

Ocular Capabilities

Our global team of industry-leading scientists employ a variety of state-of-the-art techniques and imaging modalities to investigate the pharmacodynamics (PD), pharmacokinetics (PK) and safety of novel compounds targeted to treat ocular diseases.

Corneal neovascularization, choroidal neovascularization, cataract, glaucoma, and dry eye models are currently available from JOINN (China). Biomere (USA) has a variety of ocular models under development and has interest in collaborative model development on new and unique ocular models. Our combined preclinical and clinical research experience distinctively positions us to support our clients’ nonclinical ophthalmic needs.

COMPREHENSIVE DOSING TECHNIQUES SPECIES
Topical eye Mouse, rat, rabbit, NHP
Intravitreal injection Mouse, rat, rabbit, NHP
Subretinal injection Mouse, rat, rabbit, NHP
Subconjunctival injection Mouse, rat, rabbit, NHP
Intracameral injection Mouse, rat, rabbit, NHP
Suprachoroidal Rabbit, NHP
Systemic delivery including oral, subcutaneous, intraperitoneal, intrathecal, intratracheal, and intravenous Mouse, rat, rabbit, NHP
**Ocular models (such as corneal neovascularization, choroidal neovascularization, cataract, glaucoma, and dry eye) currently available with our partner, JOINN, in China.

GLOBAL PORTFOLIO OF CRO RESOURCES SUPPORTING THE DEVELOPMENT OF OPHTHALMIC DRUGS & DEVICES

(CH=China)

Rainbow Eye
  • Early discovery through phase I clinical studies
  • GLP (CH)
  • Efficacy and proof of concept studies
  • Tolerance and safety studies
  • Pharmacokinetics studies
  • Genetic animal models
  • Comprehensive dosing techniques
  • State-of-the-art ocular technology
  • Specialized surgical procedures
  • Tissue collection and analysis
  • Histology and pathology (CH)

OCULAR MODELS

  • Dry Eye (CH)
  • Allergic Conjunctivitis (MA, CH)
  • Corneal Neovascularization (CH)
  • Corneal Degeneration (CH)
  • Corneal Wound (MA, CH)
  • Cataract (CH)
  • Rodent Laser CNV (MA, CH)
  • Uveitis (MA, CH)
  • Acute & Chronic Glaucoma (MA, CH)
  • Retinal Optic Nerve Damage (CH)
  • Retinal Neovasularization (MA, CH)
  • Retinopathy of Prematurity (CH)
  • Sodium Iodate (MA, CH)
  • Diabetic Retinopathy (CH)
  • Wet & Dry AMD (MA, CA)
Corneal Wound Model
Rodent Sodium Iodate
Mouse Subretinal Injections
Rodent Laser CNV - Histology Slides
Example of IVIS Use in a Rat Eye, Auto Florescene After Gene Therapy in a Mouse Eye
OcularB2

JOINN’s ophthalmology laboratory was established in 2012, in Suzhou. GLP compliant study services are championed by a scientific research team of 35+ professionals. This team is responsible for more than 500 service contracts assisting clients to complete 30 domestic and global IND submissions. Click here to view the JOINN Ocular Photo Gallery.

  • AAALAC Accredited
  • US FDA GLP Inspected
  • NMPA GLP Certified
  • OECD GLP Certified
  • PMDA GLP Inspected
  • MFDS GLP Inspected
  • CNAS/ILAC-MRA Certified
ASSESSMENT SPECIES EQUIPMENT
Slit-lamp/anterior segment Mouse, rat, rabbit, NHP Kowa handheld sli-lamp, Topcon slit-lamp, leica surgical scope
Indirect ophthalmoscope/fundus Mouse, rat, rabbit, NHP Keeler indirect, Volk PictorPlus
Optical coherence tomography (OCT) Mouse, rat, rabbit, NHP Heidelberg Spectralis OCT +HRA
Electroretinogram (ERG) Rabbit, NHP* Diagnosys Espion
Intra ocular pressure (IOP) Rabbit, NHP* Tonovet
Gene expression Mouse and rat, (rabbit and NHP ex vivo) IVIS Spectrum

Connect to the Global Liaison Team for more information regarding conducting studies JOINN/China.

Ocular Team

Sarah Webb

Scientist I

Large Animal Study Director Ophthalmology

Eric Xie, MD, PhD

Director of Ophthalmology

JOINN Laboratories

Our global liaison team paves the way to extended resources, abundant pharmacology models and budget friendly options seamlessly.